dc.creatorOliveira
dc.creatorJM; Allert
dc.creatorR; East
dc.creatorCE
dc.date2016
dc.date2016-12-06T18:31:30Z
dc.date2016-12-06T18:31:30Z
dc.date.accessioned2018-03-29T02:04:08Z
dc.date.available2018-03-29T02:04:08Z
dc.identifier1361-6137
dc.identifierCochrane Database Of Systematic Reviews. WILEY-BLACKWELL, n. 3, p. .
dc.identifier1469-493X
dc.identifierWOS:000373475200010
dc.identifier10.1002/14651858.CD005944.pub3
dc.identifierhttp://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005944.pub2/abstract
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/320311
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1311077
dc.descriptionIn areas where vitamin A deficiency (VAD) is a public health concern, the maternal dietary intake of vitamin A may be not sufficient to meet either the maternal nutritional requirements, or those of the breastfed infant, due the low retinol concentrations in breast milk. Objectives To evaluate the effects of vitamin A supplementation for postpartum women on maternal and infant health. Search methods We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (8 February 2016), LILACS (1982 to December 2015), Web of Science (1945 to December 2015), and the reference lists of retrieved studies. Selection criteria Randomised controlled trials (RCTs) or cluster-randomised trials that assessed the effects of vitamin A supplementation for postpartum women on maternal and infant health (morbidity, mortality and vitamin A nutritional status). Data collection and analysis Two review authors independently assessed trials for inclusion, conducted data extraction, assessed risk of bias and checked for accuracy. We assessed the quality of the evidence using the GRADE approach. Main results Fourteen trials of mainly low or unclear risk of bias, enrolling 25,758 women and infant pairs were included. The supplementation schemes included high, single or double doses of vitamin A (200,000 to 400,000 internation units (IU)), or 7.8 mg daily beta-carotene compared with placebo, no treatment, other (iron); or higher (400,000 IU) versus lower dose (200,000 IU). In all trials, a considerable proportion of infants were at least partially breastfed until six months.
dc.description
dc.description
dc.description
dc.description
dc.descriptionCochrane Editorial Unit, UK
dc.description
dc.description
dc.description
dc.languageEnglish
dc.publisherWILEY-BLACKWELL
dc.publisherHOBOKEN
dc.relationCochrane Database of Systematic Reviews
dc.rightsaberto
dc.sourceWOS
dc.subjectPostpartum Period
dc.subjectInfant Mortality
dc.subjectMaternal Mortality
dc.subjectMilk, Human [chemistry]
dc.subjectRandomized Controlled Trials As Topic
dc.subjectVitamin A [*administration & Dosage
dc.subjectAnalysis]
dc.subjectVitamin A Deficiency [drug Therapy]
dc.subjectVitamins [*administration & Dosage]
dc.subjectFemale
dc.subjectHumans
dc.subjectInfant
dc.subjectInfant
dc.subjectNewborn
dc.subjectPregnancy
dc.titleVitamin A Supplementation For Postpartum Women
dc.typeResenha


Este ítem pertenece a la siguiente institución